Abstract
Trans women have been understudied in the Hepatitis C virus (HCV) epidemic, yet data suggest they may be at elevated risk of the disease. Using data collected from the Centers for Disease Control and Prevention’s (CDC) National HIV Behavioral Surveillance (NHBS) survey, we measured HCV seropositivity, viremia, and associated risk factors for HCV infection among trans women in San Francisco from June 2019 to February 2020. Respondent-driven sampling (RDS) was used to obtain a diverse, community-based sample of 201 trans women, of whom 48 (23.9%, 95% CI 17.9% - 30.0%) were HCV seropositive. HCV seropositivity significantly increased with increasing age (adjusted prevalence ratio [APR] 1.04 per year, 95% CI 1.01–1.07) and history of injection drug use (APR 4.44, 95% CI 2.15–9.18). We also found that many had HCV viremia as twelve (6.0% of the total sample, 95% CI 2.7% - 9.3%) were RNA-positive for HCV. Trans women are highly impacted by HCV and could benefit from access to regular and frequent HCV screening and treatment access. HCV screening could be offered regularly in trans-specific health services, in the community, in jails and prisons, and integrated syringe exchange programs where treatment access or referral are also available.
Funder
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Publisher
Public Library of Science (PLoS)
Reference36 articles.
1. Methods of transmission of hepatitis C;CJ Tibbs;J Viral Hepat,1995
2. Spontaneous Resolution of Chronic Hepatitis C Virus Infection: Are We Missing Something?;GM Lauer;Clinical Infectious Diseases,2006
3. Association of Public Health Laboratories (APHL). Infectious Diseases; 2019 [cited 2019 June 25]. Interpretation of Hepatitis C Virus Test Results: Guidance for Laboratories. Available from: https://www.aphl.org/aboutAPHL/publications/Documents/ID-2019Jan-HCV-Test-Result-Interpretation-Guide.pdf.
4. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team;MJ Alter;N Engl J Med,1992
5. Hepatitis C RNA Qualitative Testing: Test of Hepatitis C—Viral Hepatitis and Liver Disease 2019. Available from: https://www.hepatitis.va.gov/hcv/patient/diagnosis/labtests-RNA-qualitative-testing.asp.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献